-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bi7mv/x8WAjFfcpSjtORZWDaNObv+BBiq/QAlC71AKmhm6Rb5W7hyie0oV0ubvox OInEX+1lHOjrndnX9QzUdA== 0001209191-08-020419.txt : 20080327 0001209191-08-020419.hdr.sgml : 20080327 20080327164507 ACCESSION NUMBER: 0001209191-08-020419 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080326 FILED AS OF DATE: 20080327 DATE AS OF CHANGE: 20080327 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIFECORE BIOMEDICAL INC CENTRAL INDEX KEY: 0000028626 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 410948334 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3515 LYMAN BLVD CITY: CHASKA STATE: MN ZIP: 55318-3051 BUSINESS PHONE: 6123684300 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC INC DATE OF NAME CHANGE: 19861214 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN MEDICAL RESEARCH INC DATE OF NAME CHANGE: 19691118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EMERSON MARTIN J CENTRAL INDEX KEY: 0001230453 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-04136 FILM NUMBER: 08715545 BUSINESS ADDRESS: STREET 1: 10700 BREN ROAD WEST CITY: MINNETONKA STATE: MN ZIP: 55343 BUSINESS PHONE: 9529306515 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2008-03-26 1 0000028626 LIFECORE BIOMEDICAL INC LCBM 0001230453 EMERSON MARTIN J 4659 FABLE HILL WAY NORTH HUGO MN 55038 1 0 0 0 Stock Option (Right to Buy) 14.70 2008-03-26 4 D 0 3750 2.30 D 2016-06-15 Common Stock 3750 0 D Stock Option (Right to Buy) 16.79 2008-03-26 4 D 0 7500 0.21 D 2016-11-16 Common Stock 7500 0 D Stock Option (Right to Buy) 12.46 2008-03-26 4 D 0 7500 4.54 D 2017-11-14 Common Stock 7500 0 D This option was canceled in the merger in exchange for a cash payment by Lifecore Biomedical, representing the difference between the exercise price of the option and $17.00 per share, the price set in the tender offer. 100% exercisable. In connection with the February 21, 2008 commencement of the tender offer to purchase all the outstanding common stock of Lifecore at $17.00 per share, all of the outstanding stock options became fully vested and exercisable in their entirety on that date. /s/ Martin J. Emerson 2008-03-26 -----END PRIVACY-ENHANCED MESSAGE-----